Werkgroep Cardiologische centra Nederland

ATLAS-1 (Completed)

Anti-Xa Therapy to Lower cardiovascular events in addition to Aspirin with or without thienopyridine therapy in Subjects with Acute Coronary Syndrome
Medicine
rivaroxaban
Population
ASCVD
Phase
II
Starting year
2001
More information
ClinicalTrials.gov